Archive - April 2019
CAR-T player Autolus seeks $100m from follow-on financing
Novo Nordisk and Gilead join forces in NASH
Intercept builds its case for Ocaliva in NASH, but safety still an issue
MSD’s Keytruda granted FDA extension
Latest NHS stats show “strain on an already overstretched system”
New Brexit date is a ‘relief’, says NHS Confederation
Maintenance immunotherapy disappoints in SCLC
EMA confirms path for Diurnal’s Chronocort despite trial failure